Literature DB >> 23410814

Combined bevacizumab and triamcinolone acetonide injections for macular edema in a patient with astrocytic hamartomas and tuberous sclerosis.

Marcela Lonngi1, Aaron S Gold, Timothy G Murray.   

Abstract

Retinal astrocytic hamartoma or retinal astrocytoma is the best-known ocular manifestation of tuberous sclerosis complex, a neurocutaneous syndrome characterized by the development of multiple disseminated hamartomas. It can have several clinical presentations, ranging from unilateral transparent, noncalcified lesions to bilateral multinodular, mulberry-like calcified tumors. Symptoms appear if the tumor involves the macula and can cause visual loss on the basis of progressive retinal degeneration. The authors report a case of a patient with tuberous sclerosis, bilateral astrocytic hamartomas, and macular edema with intraretinal hemorrhage in the left eye that has responded well to treatment with bevacizumab and intravitreal triamcinolone acetonide. Copyright 2013, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23410814     DOI: 10.3928/23258160-20121221-19

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging Retina        ISSN: 2325-8160            Impact factor:   1.300


  2 in total

1.  Mammalian target of rapamycin inhibitors for the treatment of astrocytic hamartoma in tuberous sclerosis complex (TSC).

Authors:  Ofri Vorobichik Berar; Michal Tzadok; Ofira Zloto; Iris Moroz; Idan Hecht; Anne Ampaire Musika; Omer Shlomovitz; Ido-Didi Fabian; Vicktoria Vishnevskia Dai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-01       Impact factor: 3.535

2.  A Case of Proliferative Retinopathy Complicated with Tuberous Sclerosis Treated by Vitreous Surgery.

Authors:  Emika Nemoto; Seita Morishita; Mari Akashi; Ryohsuke Kohmoto; Masanori Fukumoto; Hiroyuki Suzuki; Takatoshi Kobayashi; Teruyo Kida; Jun Sugasawa; Tsunehiko Ikeda
Journal:  Case Rep Ophthalmol       Date:  2016-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.